Watson Syndrome; Wtsn

Description

Watson syndrome is an autosomal dominant disorder characterized by pulmonic stenosis, cafe-au-lait spots, decreased intellectual ability (Watson, 1967), and short stature (Partington et al., 1985). Most affected individuals have relative macrocephaly and Lisch nodules and about one-third of those affected have neurofibroma (Allanson et al., 1991).

Clinical Features

Top most frequent phenotypes and symptoms related to Watson Syndrome; Wtsn

  • Intellectual disability
  • Short stature
  • Hearing impairment
  • Macrocephaly
  • Pulmonic stenosis
  • Abnormality of the cardiovascular system
  • Cafe-au-lait spot
  • Relative macrocephaly
  • Neurofibromas
  • Multiple cafe-au-lait spots

And another 2 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

Not enough data available about incidence and published cases.
No data available about the known clinical features onset.

Alternative names

Watson Syndrome; Wtsn Is also known as cafe-au-lait spots with pulmonic stenosis, pulmonic stenosis with cafe-au-lait spots.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Watson Syndrome; Wtsn Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Neurofibromatosis Type 1 Deletion Test.

By Athena Diagnostics Inc (United States).

NF1
Specificity
100 %
Genes
100 %
Neurofibromatosis Type 1 (NF1) Evaluation.

By Athena Diagnostics Inc (United States).

NF1
Specificity
100 %
Genes
100 %
Neurofibromatosis Type 1 DNA Sequencing Test.

By Athena Diagnostics Inc (United States).

NF1
Specificity
100 %
Genes
100 %
NGS RASopathy Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

RIT1, RRAS, BRAF, SOS1, SOS2, CBL, SHOC2, KAT6B, SPRED1, A2ML1, CABIN1, NSUN2, HRAS, KRAS, LZTR1, MAP2K1, MAP2K2, NF1, NF2, NRAS , (...)

View the complete list with 3 more genes
Specificity
5 %
Genes
100 %
Neurofibromatosis Syndrome Type 1.

By Center for Human Genetics, Inc (United States).

NF1
Specificity
100 %
Genes
100 %
Neurofibromatosis-Noonan syndrome.

By Center for Human Genetics, Inc (United States).

NF1
Specificity
100 %
Genes
100 %
Neurofibromatosis 1 Sequencing.

By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital (United States).

NF1
Specificity
100 %
Genes
100 %
Neurofibromatosis 1 Deletion/Duplication analysis.

By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital (United States).

NF1
Specificity
100 %
Genes
100 %

We have 272 more panels available in our App

Get the app

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more